NextCell Pharma AB (STO:NXTCL)

NextCell Pharma AB Statistics

Total Valuation

STO:NXTCL has a market cap or net worth of SEK 125.87 million. The enterprise value is 109.16 million.

Market Cap	125.87M
Enterprise Value	109.16M

Important Dates

The next estimated earnings date is Thursday, October 23, 2025.

Earnings Date	Oct 23, 2025
Ex-Dividend Date	n/a

Share Statistics

STO:NXTCL has 111.39 million shares outstanding. The number of shares has increased by 103.17% in one year.

Current Share Class	111.39M
Shares Outstanding	111.39M
Shares Change (YoY)	+103.17%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	9.23%
Owned by Institutions (%)	24.80%
Float	88.46M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	12.29
PB Ratio	3.06
P/TBV Ratio	3.06
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.75
EV / Sales	10.66
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.84

Financial Position

The company has a current ratio of 4.57

Current Ratio	4.57
Quick Ratio	3.00
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-39,287.34

Financial Efficiency

Return on equity (ROE) is -90.26% and return on invested capital (ROIC) is -57.75%.

Return on Equity (ROE)	-90.26%
Return on Assets (ROA)	-44.89%
Return on Invested Capital (ROIC)	-57.75%
Return on Capital Employed (ROCE)	-89.61%
Revenue Per Employee	426,623
Profits Per Employee	-1.66M
Employee Count	24
Asset Turnover	0.18
Inventory Turnover	21.40

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -9.84% in the last 52 weeks. The beta is 0.18, so STO:NXTCL's price volatility has been lower than the market average.

Beta (5Y)	0.18
52-Week Price Change	-9.84%
50-Day Moving Average	1.13
200-Day Moving Average	1.88
Relative Strength Index (RSI)	44.20
Average Volume (20 Days)	175,423

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, STO:NXTCL had revenue of SEK 10.24 million and -39.76 million in losses. Loss per share was -0.57.

Revenue	10.24M
Gross Profit	-4.06M
Operating Income	-40.70M
Pretax Income	-39.76M
Net Income	-39.76M
EBITDA	-38.16M
EBIT	-40.70M
Loss Per Share	-0.57

Balance Sheet

The company has 16.71 million in cash and n/a in debt, giving a net cash position of 16.71 million or 0.15 per share.

Cash & Cash Equivalents	16.71M
Total Debt	n/a
Net Cash	16.71M
Net Cash Per Share	0.15
Equity (Book Value)	41.09M
Book Value Per Share	0.56
Working Capital	24.20M

Cash Flow

In the last 12 months, operating cash flow was -36.05 million and capital expenditures -2.45 million, giving a free cash flow of -38.49 million.

Operating Cash Flow	-36.05M
Capital Expenditures	-2.45M
Free Cash Flow	-38.49M
FCF Per Share	-0.35

Margins

Gross Margin	-39.61%
Operating Margin	-397.52%
Pretax Margin	-388.33%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

STO:NXTCL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-103.17%
Shareholder Yield	-103.17%
Earnings Yield	-31.59%
FCF Yield	-30.58%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

STO:NXTCL has an Altman Z-Score of 0.5 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.5
Piotroski F-Score	3